Enovis CorpENOV
▲ PositiveRegulationrelevance
CMS reversed reimbursement cuts for Enovis's bone growth stimulators
Impact on stocks 1
Health Care
Enovis CorpEnovis Stock Jumps 15% After CMS Reverses Reimbursement Cuts
Regulation
Shares of Enovis Corporation jumped 15% after the Centers for Medicare & Medicaid Services reversed previously announced reimbursement cuts for the company's non-invasive bone growth stimulators. The decision marks a significant rebound for the stock, which had declined 12% during a prior session. The positive move was also supported by broader strength in the healthcare sector, which was the top-performing sector in the S&P 500 after a soft June jobs report dampened expectations for interest rate hikes.
Enovis CorpCMS reversed reimbursement cuts for Enovis's bone growth stimulators